Virokines in the pathogenesis of cancer: focus on human herpesvirus 8
- PMID: 15650258
- DOI: 10.1196/annals.1322.038
Virokines in the pathogenesis of cancer: focus on human herpesvirus 8
Abstract
During evolution, DNA viruses have captured a broad array of cellular genes involved in immune recognition and growth control that are nonessential for viral replication. The encoded virokines and viroceptors may act as mimetics or antagonists of their cellular homologues, altering signal transduction and cell communication towards survival of virus-infected cells. Human herpesvirus type 8 (HHV8) is the most recently identified human oncogenic herpesvirus. It is associated with Kaposi's sarcoma and lymphoproliferative diseases, such as pleural effusion lymphomas and multicentric Castleman's disease. HHV8 has captured a unique number of cellular regulatory genes, which redirect gene expression and cell growth, prevent apoptosis and immune recognition, and interfere with tumor suppressor gene function. HHV8 encodes a unique virokine, viral interleukin-6, which is particularly relevant for the pathogenesis of HHV8-associated tumors, since it participates in transformation and mediates autocrine and paracrine mitogenic and proinflammatory effects. Viral IL-6 differs fundamentally from human IL-6 in receptor engagement for signal transduction and thus constitutes a singular model to understand the facets of human and viral cytokine biology. We provide an overview of the role of virokines in cancer, with a particular focus on the differences of human and viral IL-6 in the pathophysiology of HHV8-associated tumors.
Similar articles
-
Modulation of cell signaling pathways by Kaposi's sarcoma-associated herpesvirus (KSHVHHV-8).Cell Biochem Biophys. 2004;40(3):305-22. doi: 10.1385/CBB:40:3:305. Cell Biochem Biophys. 2004. PMID: 15211030 Review.
-
The pleiotropic effects of Kaposi's sarcoma herpesvirus.J Pathol. 2006 Jan;208(2):187-98. doi: 10.1002/path.1904. J Pathol. 2006. PMID: 16362980 Review.
-
Immune evasion by Kaposi's sarcoma-associated herpesvirus.Nat Rev Immunol. 2007 May;7(5):391-401. doi: 10.1038/nri2076. Nat Rev Immunol. 2007. PMID: 17457345 Review.
-
Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.Cancer Res. 2005 Mar 1;65(5):1738-47. doi: 10.1158/0008-5472.CAN-04-2374. Cancer Res. 2005. PMID: 15753369
-
Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.Pathol Int. 2006 Oct;56(10):617-24. doi: 10.1111/j.1440-1827.2006.02017.x. Pathol Int. 2006. PMID: 16984619
Cited by
-
Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor.J Virol. 2009 May;83(10):5117-26. doi: 10.1128/JVI.01601-08. Epub 2009 Mar 4. J Virol. 2009. PMID: 19264784 Free PMC article.
-
ErbB1-4-dependent EGF/neuregulin signals and their cross talk in the central nervous system: pathological implications in schizophrenia and Parkinson's disease.Front Cell Neurosci. 2013 Feb 13;7:4. doi: 10.3389/fncel.2013.00004. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23408472 Free PMC article.
-
Suppression of KSHV-induced angiopoietin-2 inhibits angiogenesis, infiltration of inflammatory cells, and tumor growth.Cell Cycle. 2016 Aug 2;15(15):2053-65. doi: 10.1080/15384101.2016.1196303. Epub 2016 Jun 13. Cell Cycle. 2016. PMID: 27294705 Free PMC article.
-
IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.Int J Biol Sci. 2012;8(9):1237-47. doi: 10.7150/ijbs.4989. Epub 2012 Oct 24. Int J Biol Sci. 2012. PMID: 23136552 Free PMC article. Review.
-
Host-virus interaction and viral evasion.Cell Biol Int. 2021 Jun;45(6):1124-1147. doi: 10.1002/cbin.11565. Epub 2021 Feb 19. Cell Biol Int. 2021. PMID: 33533523 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
